"ANTIPSYCHOTIKA V L\u00C9\u010CB\u011A \u00DAZKOSTN\u00DDCH PORUCH"@cs . "P(NS10301)" . "ANTIPSYCHOTICS IN THE TREATMENT OF ANXIETY DISORDERS"@en . "CZ - \u010Cesk\u00E1 republika" . . . "[D6CADA128E70]" . "3" . "RIV/61989592:15110/12:33146637!RIV14-MZ0-15110___" . . . "2"^^ . "RIV/61989592:15110/12:33146637" . . . "Psychiatrie : \u010Dasopis pro modern\u00ED psychiatrii" . "Antipsychotika se pou\u017E\u00EDvaj\u00ED pro l\u00E9\u010Dbu patologick\u00E9 \u00FAzkosti ji\u017E n\u011Bkolika generacemi psychiatr? p\u0159esto, \u017Ee d\u016Fkazy o jejich \u00FA\u010Dinnosti v t\u00E9to indikaci nejsou dostate\u010Dn\u00E9. Obzvl\u00E1\u0161t\u011B antipsychotika druh\u00E9 generace jsou ve zv\u00FD\u0161en\u00E9 m\u00ED\u0159e pou\u017E\u00EDv\u00E1na p\u0159i l\u00E9\u010Db\u011B nepsychotick\u00E9 \u00FAzkosti, a to obzvl\u00E1\u0161t\u011B pro jejich slu\u0161n\u00FD bezpe\u010Dnostn\u00ED profil. Zdrojem liter\u00E1rn\u00ED re\u0161er\u0161e na toto t\u00E9ma byly \u010Dl\u00E1nky z datab\u00E1z\u00ED PubMed a Web of Science publikovan\u00E9 v letech 1991-2011. Dal\u0161\u00ED reference byly z\u00EDsk\u00E1ny z bibliografie relevantn\u00EDch \u010Dl\u00E1nk?. Z literatury vypl\u00FDvaj\u00ED st\u0159edn\u011B siln\u00E9 d?kazy pro podporu pou\u017Eit\u00ED n\u011Bkter\u00FDch antipsychotik bu\u010F jako p\u0159\u00EDdatn\u00E9 l\u00E9\u010Dby, nebo p\u0159i monoterapii \u00FAzkostn\u00FDch poruch. P\u0159es omezen\u00E9 mno\u017Estv\u00ED klinick\u00FDch studi\u00ED, kter\u00E9 byly na toto t\u00E9ma provedeny, p\u0159edstavuj\u00ED atypick\u00E1 antipsychotika slibn\u00FD zp\u016Fsob l\u00E9\u010Dby, zejm\u00E9na s ohledem na profil jejich ne\u017E\u00E1douc\u00EDch \u00FA\u010Dink\u016F p\u0159i srovn\u00E1n\u00ED s konven\u010Dn\u00EDmi l\u00E1tkami. D\u016Fkazy, kter\u00E9 v sou\u010Dasnosti m\u00E1me, nejsou dostate\u010Dn\u00E9 pro indikaci antipsychotik druh\u00E9 generace jako prvn\u00ED volby p\u0159i l\u00E9\u010Db\u011B \u00FAzkostn\u00FDch poruch." . "antiepileptics; anxiolytics; antidepressants; treatment resistance; anxiety disorders; antipsychotics"@en . . . "2"^^ . "ANTIPSYCHOTIKA V L\u00C9\u010CB\u011A \u00DAZKOSTN\u00DDCH PORUCH" . "122999" . . . "Antipsychotika se pou\u017E\u00EDvaj\u00ED pro l\u00E9\u010Dbu patologick\u00E9 \u00FAzkosti ji\u017E n\u011Bkolika generacemi psychiatr? p\u0159esto, \u017Ee d\u016Fkazy o jejich \u00FA\u010Dinnosti v t\u00E9to indikaci nejsou dostate\u010Dn\u00E9. Obzvl\u00E1\u0161t\u011B antipsychotika druh\u00E9 generace jsou ve zv\u00FD\u0161en\u00E9 m\u00ED\u0159e pou\u017E\u00EDv\u00E1na p\u0159i l\u00E9\u010Db\u011B nepsychotick\u00E9 \u00FAzkosti, a to obzvl\u00E1\u0161t\u011B pro jejich slu\u0161n\u00FD bezpe\u010Dnostn\u00ED profil. Zdrojem liter\u00E1rn\u00ED re\u0161er\u0161e na toto t\u00E9ma byly \u010Dl\u00E1nky z datab\u00E1z\u00ED PubMed a Web of Science publikovan\u00E9 v letech 1991-2011. Dal\u0161\u00ED reference byly z\u00EDsk\u00E1ny z bibliografie relevantn\u00EDch \u010Dl\u00E1nk?. Z literatury vypl\u00FDvaj\u00ED st\u0159edn\u011B siln\u00E9 d?kazy pro podporu pou\u017Eit\u00ED n\u011Bkter\u00FDch antipsychotik bu\u010F jako p\u0159\u00EDdatn\u00E9 l\u00E9\u010Dby, nebo p\u0159i monoterapii \u00FAzkostn\u00FDch poruch. P\u0159es omezen\u00E9 mno\u017Estv\u00ED klinick\u00FDch studi\u00ED, kter\u00E9 byly na toto t\u00E9ma provedeny, p\u0159edstavuj\u00ED atypick\u00E1 antipsychotika slibn\u00FD zp\u016Fsob l\u00E9\u010Dby, zejm\u00E9na s ohledem na profil jejich ne\u017E\u00E1douc\u00EDch \u00FA\u010Dink\u016F p\u0159i srovn\u00E1n\u00ED s konven\u010Dn\u00EDmi l\u00E1tkami. D\u016Fkazy, kter\u00E9 v sou\u010Dasnosti m\u00E1me, nejsou dostate\u010Dn\u00E9 pro indikaci antipsychotik druh\u00E9 generace jako prvn\u00ED volby p\u0159i l\u00E9\u010Db\u011B \u00FAzkostn\u00FDch poruch."@cs . . "1211-7579" . "Antipsychotics were used in the treatment of pathological anxiety by several generations of psychiatrists despite the insufficient evidence. Because of their somewhat improved safety profile, especially second generation antipsychotics (SGAs) are increasingly used for the treatment of non-psychotic anxiety. The resources for this literature review were obtained from the National Library of Medicine PubMed database and Web of Science, including the ones published between the years 1991-2011. Additional references were found through bibliography reviews of relevant articles. There is moderate evidence supporting the use of some antipsychotics, either as adjunctive treatment or monotherapy, in the treatment of anxiety disorders. Despite the limitations of the trials reviewed, atypical antipsychotics represent a promising treatment modality when considering their improved side effect profile compared to conventional agents. The facts to date do not warrant the use of SGAs as first-line monotherapy in the treatment of anxiety disorders."@en . "15110" . . "ANTIPSYCHOTIKA V L\u00C9\u010CB\u011A \u00DAZKOSTN\u00DDCH PORUCH"@cs . . "ANTIPSYCHOTICS IN THE TREATMENT OF ANXIETY DISORDERS"@en . . . "11"^^ . . . . "Pra\u0161ko Pavlov, J\u00E1n" . . "ANTIPSYCHOTIKA V L\u00C9\u010CB\u011A \u00DAZKOSTN\u00DDCH PORUCH" . "L\u00E1talov\u00E1, Kl\u00E1ra" . . "16" .